# Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)

> **NCT04444349** · NA · RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 500 (estimated)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** Coenzyme Q10
- **DIETARY_SUPPLEMENT:** Standard Medical Therapy

## Key facts

- **NCT ID:** NCT04444349
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04444349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04444349, "Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04444349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*